Sherwood Forest Hospitals NHS Foundation Trust, in partnership with Nottingham Trent University (NTU) and West ...

Despite a recent 45% rally, I maintain a 'Sell' view on CVS due to its underwhelming execution record and rising leverage ...

Earnings have fallen but are still strong enough to meet CVS Health's dividend commitment. Management expects adjusted earnings for 2025 to land in a range between $5.75 and $6 per share. That's ...

We recently published a list of the 10 Best Performing Healthcare Stocks So Far in 2025. In this article, we are going to ...

In the latest executive shakeup at CVS, the pharmacy giant has named a new president of its pharmacy benefit management ...

HARTFORD-- This week, the CEO of CVS Health expressed confidence that the company would turn around its embattled health-insurance business, the Hartford- based Aetna. "People used to refer to Aetna ...

Argus raised the firm’s price target on CVS Health (CVS) to $77 from $68 and keeps a Buy rating on the shares. Despite an uneven performance ...

In a report released on February 14, Steven Silver from Argus Research maintained a Buy rating on CVS Health (CVS – Research Report). The ...

In this article, we are going to take a look at where CVS Health Corporation (NYSE:CVS) stands against the other stocks. Emily Rowland, co-chief investment strategist at John Hancock Investment ...

CVS Health has named Ed DeVaney as president of CVS Caremark. Mr. DeVaney was appointed interim president of the pharmacy benefit manager in December, according to a Feb. 17 news release from CVS ...

Lynch, the former president and CEO of CVS Health Corporation (NYSE: NYSE:CVS), has joined its board of directors. The appointment, effective immediately, increases the number of board members to 12.